MedTrace Logo

Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes

NCT02806349 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2016-06-20

No results posted yet for this study

Summary

The purpose of this study was to determine whether the co-administration of a konjac-glucomannan fibre blend and American ginseng in a randomized, placebo-controlled, cross-over trial can improve diabetes management.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

American Ginseng

herb

DIETARY_SUPPLEMENT

Konjac-glucomannan fiber blend

Blend of 2 viscous fibers: konjac mannan and xanthan

DIETARY_SUPPLEMENT

Control

Fiber matched control for intervention (corn starch and wheat bran)

Sponsors & Collaborators

  • Canadian Diabetes Association

    collaborator OTHER

  • Vladimir Vuksan

    lead OTHER

Principal Investigators

  • Vladimir Vuksan, PhD · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Primary Completion
2004-11-30
Completion
2005-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02806349 on ClinicalTrials.gov